Top Suppliers:I want be here


341519-04-8

341519-04-8 structure
341519-04-8 structure

Name H-p-Chloro-Phe-D-Cys-β-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2
Synonyms H-p-Chloro-Phe-D-Cys-b-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2
Description PRL 3195 is a somatostatin receptor antagonist with Kis of 6, 17, 66, 1000 and 1000 nM for human somatostatin receptors (sst5, sst2, sst3, sst1 and sst4, respectively)[1].
Related Catalog
Target

hsst5:6 nM (Ki)

hsst2:17 nM (Ki)

hsst3:66 nM (Ki)

hsst1:1000 nM (Ki)

hsst4:1000 nM (Ki)

rat urotensin II receptor:429 nM (Ki)

human urotensin II receptor:1846 nM (Ki)

In Vitro PRL 3195 抑制人尿紧素 II (human urotensin II) 诱导的大鼠主动脉相位振荡,ED50 为 24 nM[1]。
References

[1]. Rossowski WJ, et al. Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists. Eur J Pharmacol. 2002 Mar 8;438(3):159-70.  

Molecular Formula C58H71ClN12O9S2
Molecular Weight 1179.84000
Exact Mass 1178.46000
PSA 416.55000
LogP 6.00420